23.04.2024 13:27:06 - dpa-AFX: ROUNDUP: Quest Diagnostics Lifts FY24 Outlook After Q1 Profit Beats View; Stock Up In Pre-market

WASHINGTON (dpa-AFX) - Quest Diagnostics (DGX), while reporting weak profit
in its first quarter despite higher revenues, on Tuesday raised its fiscal 2024
forecast.

In pre-market activity on the NYSE, Quest shares were gaining around 3 percent
to trade at $134.04.

For the year, the company now expects earnings per share between $7.57 and $7.82
and adjusted earnings per share between $8.72 and $8.97.

The company previously expected reported earnings per share of $7.69 to $7.99,
and adjusted earnings of $8.60 to $8.90 per share.

Full year 2024 revenues are now expected to be between $9.40 billion and $9.48
billion, while previous outlook was $9.35 billion to $9.45 billion.

Analysts on average expect the company to report earnings of $8.75 per share on
revenues of $9.4 billion, according to figures compiled by Thomson Reuters.
Analysts' estimates typically exclude special items.

In its first quarter, Quest Diagnostics' earnings decreased from the same period
last year but beat the Street estimates.

The company's bottom line came in at $194 million, or $1.72 per share. This
compares with $202 million, or $1.78 per share, in last year's first quarter.

Adjusted earnings of $230 million or $2.04 per share for the period. Analysts
had expected the company to earn $1.85 per share.

The company's revenue for the quarter rose 1.7 percent to $2.37 billion from
$2.33 billion last year.

For more earnings news, earnings calendar, and earnings for stocks, visit
rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
QUEST DIAGNOSTICS DL-,01 904533 Frankfurt 127,950 10.05.24 08:04:45 +1,500 +1,19% 0,000 0,000 127,950 127,950

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH